Prescribing Symbicort

Therapeutic indications & presentation

Symbicort® (budesonide/formoterol) is indicated for adults, adolescents 12 years and older and children aged 6 years and older (100/6 Turbohaler only)1 for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting ß2-adrenoceptor agonist) is appropriate.1-4

  • Patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short acting ß2-adrenoceptor agonists or
  • Patients already adequately controlled on both inhaled corticosteroids and long acting ß2-adrenoceptor agonists.

Symbicort Turbohaler 400/12 should be used as Maintenance Therapy only. Lower strengths are available for the Symbicort Maintenance and Reliever Therapy regimen (100mcg/6mcg/inhalation Turbohaler, 200mcg/6mcg/inhalation Turbohaler and 100mcg/3mcg/inhalation pMDI).1-4

Symbicort 100/3 pMDI is to be used in the treatment of asthma and is not approved in the UK for the treatment of COPD.4

Please note that an alternative strength of Symbicort pMDI is also available (200/6 mcg/inhalation). Symbicort 200/6 pMDI is to be used in the treatment for COPD and is not approved in the UK for the treatment of asthma.5

See Summary of Product Characteristics for further information.

Symbicort cost
Symbicort cost

*Symbicort Turbohaler 100/6 Inhalation powder (120 doses), Symbicort Turbohaler 200/6 Inhalation powder (120 doses) and Symbicort Turbohaler 400/12 Inhalation powder (60 doses) are all priced at £28.00. Symbicort pMDI 100/3, actuation pressurised inhalation suspension (120 doses) is priced at £14.00